These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21513712)

  • 1. Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?
    Santegoets KC; van Bon L; van den Berg WB; Wenink MH; Radstake TR
    FEBS Lett; 2011 Dec; 585(23):3660-6. PubMed ID: 21513712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments.
    Joosten LA; Abdollahi-Roodsaz S; Dinarello CA; O'Neill L; Netea MG
    Nat Rev Rheumatol; 2016 Jun; 12(6):344-57. PubMed ID: 27170508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of TLR-dependent and independent pathways in autoimmunity].
    Kumagai Y; Akira S
    Nihon Rinsho; 2009 Mar; 67(3):487-93. PubMed ID: 19280921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.
    Clanchy FI; Sacre SM
    Expert Opin Biol Ther; 2010 Dec; 10(12):1703-16. PubMed ID: 21039312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of innate immunity in autoimmune tissue injury.
    Allam R; Anders HJ
    Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor recognition of Toxoplasma gondii.
    Yarovinsky F; Sher A
    Int J Parasitol; 2006 Mar; 36(3):255-9. PubMed ID: 16476433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.
    Ehlers M; Ravetch JV
    Trends Immunol; 2007 Feb; 28(2):74-9. PubMed ID: 17197239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors' two-edged sword: when immunity meets apoptosis.
    Salaun B; Romero P; Lebecque S
    Eur J Immunol; 2007 Dec; 37(12):3311-8. PubMed ID: 18034428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking as a trigger for inflammatory rheumatic diseases.
    Klareskog L; Padyukov L; Alfredsson L
    Curr Opin Rheumatol; 2007 Jan; 19(1):49-54. PubMed ID: 17143096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
    Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
    Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoking and autoimmune rheumatic diseases.
    Harel-Meir M; Sherer Y; Shoenfeld Y
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.
    Radstake TR; van Lieshout AW; van Riel PL; van den Berg WB; Adema GJ
    Ann Rheum Dis; 2005 Nov; 64(11):1532-8. PubMed ID: 15878905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
    O'Neill LA
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):319-27. PubMed ID: 18446139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.